FHTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Foghorn Therapeutics Inc

Watchlist Manager

Watchlist

Price: 2.1 USD -1.41% Market Closed

Market Cap: $124.7m

	Foghorn Therapeutics Inc NASDAQ:FHTX	US
B	Bank of China Ltd XMUN:W8V	CN
S	Sabre Resources Ltd F:SAL	AU
N	Noah Holdings Ltd SWB:6NO	CN
E	Eckert & Ziegler SE DUS:EUZ	DE
N	Nokia Oyj F:NOA3	FI

Profitability Summary

Foghorn Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-198%

Negative 3Y Average Operating Margin

-331%

Operating Margin is Increasing

-351% > -198%

Negative Net Margin

-176%

Negative 3Y Average Net Margin

-289%

Net Margin is Increasing

-317% > -176%

Negative Free Cash Flow Margin

-229%

Negative 3Y Average Free Cash Flow Margin

-348%

Free Cash Flow Margin is Increasing

-372% > -229%

Exceptional ROE

82%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-250%

Declining ROIC

-229% > -256%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.